Rossari Biotech Ltd, a leading specialty-chemicals manufacturer, has revealed robust financial performance for the quarter ended December 31, 2023. Revenue from operations grew by 19% to Rs 463.8 crore compared to Rs 389.3 crore in Q3 FY23. EBITDA improved by 18% to Rs 63.7 crore from Rs 54.2
